Zacks Investment Research·Jun 17, 2026
4 Cosmetics Stocks Worth Watching on Favorable Industry TrendsEL, ELF, HELE and NUS are benefiting from growing skincare demand, product innovation and expanding digital channels.
Nu Skin Enterprises, Inc.(NUS)Earnings, Financials & Key Ratios
NUS•NYSE
$5.25
1.7× P/E·Price updated Jul 2, 2026
AboutNu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.Show more
- Revenue$1.49B-14.3%
- EBITDA$143M+275.0%
- Net Income$160M+209.3%
- EPS (Diluted)3.18+207.8%
- Gross Margin69.45%+1.8%
- EBITDA Margin9.64%+304.1%
- Operating Margin6.12%+169.9%
- Net Margin10.79%+227.5%
- ROE22%+210.5%
NUS Price & Volume
Nu Skin Enterprises, Inc. (NUS) stock price & volume — 10-year historical chart
Loading chart...
Structural Revenue Erosion Challenges Direct Selling Model
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Strained
Financial:Healthy
Cash Flow:Deteriorating
Primary Risk:Regulatory and distribution contraction
Key Thesis Takeaways
- Nu Skin faces a precarious outlook as its core direct-selling model struggles with persistent top-line contraction, evidenced by a 12.0% revenue decline in 2026Q1.
- While the company has successfully reduced its debt-to-equity ratio to 0.35, the lack of operating leverage and negative free cash flow margins of -5.5% raise significant concerns regarding long-term sustainability.
- Investors should remain cautious as the company continues to prioritize shareholder returns despite a deteriorating cash flow profile and structural market headwinds.
Verdict Logic
the company's inability to generate positive free cash flow, evidenced by a -5.5% FCF margin in 2026Q1, suggests that current dividend and buyback programs may be unsustainable.
NUS Growth Metrics
Nu Skin Enterprises, Inc. (NUS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-4.06%
5 Years-10.47%
3 Years-12.61%
TTM-14.17%
Profit CAGR
10 Years1.87%
5 Years-3.49%
3 Years15.2%
TTM241.45%
EPS CAGR
10 Years3.52%
5 Years-2.61%
3 Years15.39%
TTM237.15%
Return on Capital
10 Years12.87%
5 Years4.86%
3 Years-0.1%
Last Year7.85%
NUS Recent Earnings
Nu Skin Enterprises, Inc. (NUS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.14-6.7%
$0.15
Rev
$321M-2.8%
$330M
Q1 2026
Feb 12, 2026Metric
Actual
Est
EPS
$0.29-3.3%
$0.30
Rev
$370M-3.2%
$383M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.34+13.3%
$0.30
Rev
$364M-4.8%
$383M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.43+72.0%
$0.25
Rev
$386M+2.5%
$377M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.14vs $0.15-6.7% | $321Mvs $330M-2.8% |
| Q1 2026 | Feb 12, 2026 | $0.29vs $0.30-3.3% | $370Mvs $383M-3.2% |
| Q4 2025 | Nov 6, 2025 | $0.34vs $0.30+13.3% | $364Mvs $383M-4.8% |
| Q3 2025 | Aug 7, 2025 | $0.43vs $0.25+72.0% | $386Mvs $377M+2.5% |
Based on last 12 quarters of dataView full earnings history →
Latest NUS News
Recent stock market news and headlines for Nu Skin Enterprises, Inc. (NUS)
Zacks Investment Research·Jun 16, 2026
5 Value Stocks With Low Price-to-Sales Ratios & Massive UpsideCAL, GIII, NUS, APLE and EVER screen as low price-to-sales value stocks with upside potential, backed by valuation and debt filters.
Peers Comparison
Key metrics vs top competitors for Nu Skin Enterprises, Inc. (NUS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $5.25 | $254.89M | 1.65 | -14.26% | 10.79% | 22% | 4.48% | |
| $12.99 | $1.35B | 5.90 | 0.89% | 4.67% | — | — | |
| $21.72 | $401.02M | 37.45 | 8.28% | 0.96% | 1.51% | — | |
| $21.95 | $385.99M | 20.71 | 5.67% | 4.06% | 12.08% | — | |
| $11.03 | $122.64M | -6.49 | -35.96% | -5.79% | -9.68% | — | |
| $82.47 | $29.78B | -26.18 | -8.46% | -1.67% | -6.29% | — |
Compare NUS vs Peers
Nu Skin Enterprises, Inc. (NUS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NUS SEC Filings & Documents
Nu Skin Enterprises, Inc. (NUS) SEC filings — annual & quarterly reports (10-K, 10-Q)
8-K Announcements
6Material company update
May 8, 2026·SEC
Material company update
May 7, 2026·SEC
Material company update
Mar 27, 2026·SEC
10-K Annual Reports
310-Q Quarterly Reports
6Get notified when NUS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NUS Frequently Asked Questions
Nu Skin Enterprises, Inc. (NUS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Nu Skin Enterprises, Inc.'s revenue?
Nu Skin Enterprises, Inc. (NUS) reported $1.44B in revenue for fiscal year 2025. This represents a 112% increase from $678.6M in 1996.
How fast is Nu Skin Enterprises, Inc. growing?
Nu Skin Enterprises, Inc. (NUS) saw revenue decline by 14.3% over the past year.
Is NUS profitable?
Yes, Nu Skin Enterprises, Inc. (NUS) is profitable, generating $54.5M in net income for fiscal year 2025 (10.8% net margin).
Dividend & Returns
Does NUS pay dividends?
Yes, Nu Skin Enterprises, Inc. (NUS) pays a dividend with a yield of 4.48%. This makes it attractive for income-focused investors.
What is NUS's return on equity?
Nu Skin Enterprises, Inc. (NUS) has a return on equity (ROE) of 22.0%. This is excellent, indicating efficient use of shareholder capital.
What is Nu Skin Enterprises, Inc.'s free cash flow?
Nu Skin Enterprises, Inc. (NUS) generated $41.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.